Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Triciribine phosphate monohydrate: Interim Phase I data

Interim data from a dose-escalation Phase I trial in 26 evaluable patients showed

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE